Showing results (1261-1270 of 1,478) with videos related to
Sort By:
Pageof 148
Nature Reviews. Clinical Oncology|September 13, 2017
Corrigendum: Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.Nature Communications|September 12, 2025
Matrix directs trophoblast differentiation in a bioprinted organoid model of early placental developmentClaire Richards, Hao Chen, Matthew O'Rourke, et al.Open Forum Infectious Diseases|March 11, 2026
Leptospirosis Incidence at Four Sites in Sub-Saharan Africa and South East Asia: An International Multi-Site Hybrid Surveillance StudyJohn A Crump, Mathieu Picardeau, Sara A Ajanovic, et al.Nature Reviews. Clinical Oncology|April 23, 2014
Can we deliver randomized trials of focal therapy in prostate cancer?Hashim U Ahmed, Viktor Berge, David Bottomley, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 13, 2025
Neo-adjuvant FOLFOX with and without panitumumab for patients with KRAS-wt locally advanced colon cancer: results following an extended biomarker panel on the FOxTROT trial embedded phase II populationJ F Seligmann, D Morton, F Elliott, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2022
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale (ESMO-MCBS) creditS F Oosting, J Barriuso, A Bottomley, et al.Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 19, 2013
Determinants of quality of life in advanced cancer patients with bone metastases undergoing palliative radiation treatmentKinsey Lam, Edward Chow, Liying Zhang, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 13, 2009
Adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma: a phase III randomized controlled trial of health-related quality of life and symptoms by the European Organisation for Research and Treatment of Cancer Melanoma GroupAndrew Bottomley, Corneel Coens, Stefan Suciu, et al.JCI Insight|June 2, 2026
Mapping the plasma proteomic architecture of systemic lupus erythematosusGeoffrey H D Leung, Charlotte Bottomley, Norzawani Buang, et al.The British Journal of Dermatology|July 15, 2026
Beyond the First Graft: Skin Cancer Risk and Risk Stratification in Retransplanted Solid Organ RecipientsAlessandra Rünger, Alexandra Geusau, Mirjam Nägeli, et al.Pageof 148